JPS5916881A - 血糖低下活性を有する、脂環式置換されたオキサゾリジン−２，４−ジオン - Google Patents

血糖低下活性を有する、脂環式置換されたオキサゾリジン−２，４−ジオン

Info

Publication number
JPS5916881A
JPS5916881A JP58112583A JP11258383A JPS5916881A JP S5916881 A JPS5916881 A JP S5916881A JP 58112583 A JP58112583 A JP 58112583A JP 11258383 A JP11258383 A JP 11258383A JP S5916881 A JPS5916881 A JP S5916881A
Authority
JP
Japan
Prior art keywords
title product
dione
oxazolidine
hexane
oil
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP58112583A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6230993B2 (enExample
Inventor
ジエラルド・フアガン・ホ−ランド
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of JPS5916881A publication Critical patent/JPS5916881A/ja
Publication of JPS6230993B2 publication Critical patent/JPS6230993B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D263/44—Two oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/29—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups
    • C07C45/292—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation of hydroxy groups with chromium derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/51—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition
    • C07C45/511—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups
    • C07C45/513—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by pyrolysis, rearrangement or decomposition involving transformation of singly bound oxygen functional groups to >C = O groups the singly bound functional group being an etherified hydroxyl group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/69—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by addition to carbon-to-carbon double or triple bonds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/70—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form
    • C07C45/71—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction with functional groups containing oxygen only in singly bound form being hydroxy groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/42—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings with a six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/38—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings
    • C07C47/45—Unsaturated compounds having —CHO groups bound to carbon atoms of rings other than six—membered aromatic rings having unsaturation outside the rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP58112583A 1982-06-23 1983-06-22 血糖低下活性を有する、脂環式置換されたオキサゾリジン−２，４−ジオン Granted JPS5916881A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US391220 1982-06-23
US06/391,220 US4430337A (en) 1982-06-23 1982-06-23 Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity

Publications (2)

Publication Number Publication Date
JPS5916881A true JPS5916881A (ja) 1984-01-28
JPS6230993B2 JPS6230993B2 (enExample) 1987-07-06

Family

ID=23545772

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58112583A Granted JPS5916881A (ja) 1982-06-23 1983-06-22 血糖低下活性を有する、脂環式置換されたオキサゾリジン−２，４−ジオン

Country Status (10)

Country Link
US (1) US4430337A (enExample)
EP (1) EP0097453B1 (enExample)
JP (1) JPS5916881A (enExample)
AT (1) ATE51864T1 (enExample)
CA (1) CA1197513A (enExample)
DE (1) DE3381437D1 (enExample)
DK (1) DK287883A (enExample)
ES (1) ES523521A0 (enExample)
GR (1) GR79300B (enExample)
IE (1) IE55837B1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0306525A4 (en) * 1987-03-20 1991-04-24 Alcon Laboratories Inc Use of aldose reductase inhibitors to enhance insulin sensitivity in diabetes mellitus
HU203330B (en) * 1987-06-10 1991-07-29 Pfizer Process for producing oxazolidin-2-one derivatives and hypoglychemic pharmaceutical compositions containing them
WO1991007107A1 (en) * 1989-11-13 1991-05-30 Pfizer Inc. Oxazolidinedione hypoglycemic agents
GB9017218D0 (en) * 1990-08-06 1990-09-19 Beecham Group Plc Novel compounds
US5498621A (en) * 1992-05-01 1996-03-12 Pfizer Inc. Oxazolidinedione hypoglycemic agents
US5221686A (en) * 1992-08-04 1993-06-22 American Home Products Corporation Spiro[1,2-benzisothiazole-3(2H),5'-oxazolidine]-2',4'-dione 1,1-dioxides as antihyperglycemic agents
TW268952B (enExample) 1993-02-26 1996-01-21 Takeda Pharm Industry Co Ltd
US5614544A (en) * 1993-09-14 1997-03-25 Takeda Chemical Industries, Ltd. Oxazolidinedione derivatives and their use
TW403748B (en) 1994-11-02 2000-09-01 Takeda Chemical Industries Ltd An oxazolidinedione derivative, its production and a pharmaceutical composition for lowering blood sugar and lipid in blood comprising the same
AU6331199A (en) * 1998-09-30 2000-04-17 Roche Diagnostics Gmbh Oxazolidine derivatives for the treatment and prevention of metabolic bone disorders
EP1194146B1 (en) 1999-06-18 2006-07-19 Merck & Co., Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
US6380191B1 (en) 1999-06-18 2002-04-30 Merck & Co. Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB226529A (en) 1923-12-18 1925-08-13 Arnold I Van Den Bergh S Embal Improvements in and relating to edge trimming and moulding machines for planks and laths
US2338064A (en) 1940-02-10 1943-12-28 Mallinckrodt Chemical Works Derivatives of 2,4-oxazolidinedione
US2349796A (en) 1942-01-14 1944-05-23 Mallinckrodt Chemical Works Derivatives of 2,4-oxazolidinedione
US2349795A (en) 1942-01-14 1944-05-23 Mallinckrodt Chemical Works Derivatives of 2,4-oxazolidinedione
US2349313A (en) 1943-03-01 1944-05-23 Mallinckrodt Chemical Works Derivatives of 2, 4-oxazolidinedione
US2575692A (en) 1947-10-11 1951-11-20 Abbott Lab N-methyl oxazolidine-2, 4-diones
US2575694A (en) 1949-03-02 1951-11-20 Abbott Lab 3, 5, 5-trimethyloxazolidine-2, 4-dione
US2575693A (en) 1949-03-02 1951-11-20 Abbott Lab 3, 5-dimethyl-5-ethyloxazolidine-2, 4-dione
US2961377A (en) 1957-08-05 1960-11-22 Us Vitamin Pharm Corp Oral anti-diabetic compositions and methods
US3699229A (en) * 1970-12-18 1972-10-17 Abbott Lab 2-oxo-5-phenyl-4-oxazolidinone as an anti-depressant agent
US4200642A (en) 1978-08-21 1980-04-29 Pfizer Inc. Spiro-oxazolidindiones
GT198170554A (es) * 1980-07-28 1983-01-12 5-oxazolidin-2-4-dionas hipoglicemicas substituidas.
US4332952A (en) 1980-07-28 1982-06-01 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones

Also Published As

Publication number Publication date
US4430337A (en) 1984-02-07
JPS6230993B2 (enExample) 1987-07-06
IE831461L (en) 1983-12-23
DK287883D0 (da) 1983-06-22
EP0097453A3 (en) 1985-06-12
CA1197513A (en) 1985-12-03
EP0097453B1 (en) 1990-04-11
IE55837B1 (en) 1991-01-30
ATE51864T1 (de) 1990-04-15
ES8500918A1 (es) 1984-11-01
EP0097453A2 (en) 1984-01-04
DE3381437D1 (de) 1990-05-17
GR79300B (enExample) 1984-10-22
ES523521A0 (es) 1984-11-01
DK287883A (da) 1983-12-24

Similar Documents

Publication Publication Date Title
DE3871916T2 (de) Thiazolidindione als hypoglykaemische und antiatherosklerotische mittel.
DE2933441C2 (de) Spiro-[4H-2,3-dihydrobenzopyran(4,5')oxazolidin]-2',4'-dione und solche Verbindungen enthaltende Arzneimittel
KR850000381B1 (ko) 5-치환된 옥사졸리딘-2,-4디온의 제조방법
GB1572688A (en) Spirohydantoins
CS244901B2 (en) Production method of racemic or opticaly active 5-substituted oxazolidi-2,4-diones
EP0097453B1 (en) Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
CH680000A5 (enExample)
US4220648A (en) Antidiabetic 1,2-dihydro-2-oxo-6-neopentyl-nicotinic acids
US4226875A (en) Novel spiro-oxazolidinediones
LU86012A1 (fr) Nouveaux composes naphtaleniques,leur preparation et leur application comme medicaments
EP0005091B1 (fr) Nouvelles pipérazines monosubstituées, leurs procédés de préparation et les compositions pharmaceutiques les renfermant
EP0118489A1 (en) Secondary arylethanolamines
EP1627866B1 (en) Carboxylic acid compound and medicine containing the same
US20050009909A1 (en) Carboxylic compound and medicine comprising the same
JPH0329073B2 (enExample)
US4267342A (en) Spiro-oxazolidindiones
CH648483A5 (fr) Composition pharmaceutique contre l'arthrite rhumatoide.
FR2487359A1 (fr) 11a-amino-androstanes, leur preparation et compositions en contenant
JPS6135188B2 (enExample)
CH647503A5 (fr) Derives de la 16-methoxy-16-methyl-prostaglandine e(1), procede pour leur synthese et medicaments gastro-protecteurs contenant lesdits derives.
JP2535532B2 (ja) ベンゾジオキソ−ル誘導体
FR2514762A1 (fr) Nouveaux composes a la pyridine et composition pharmaceutique les contenant
NZ209273A (en) Alkyl aryl(hydroxy)methanecarboximidates
FR2475553A1 (fr) Nouvelles spiro(4h-2,3-dihydrobenzopyranne(4,5')-oxazolidine)-2'-ones, utiles comme intermediaires chimiques
HK1085198A (en) Carboxylic acid compound and medicine containing the same